Diabetic renal disease in transitional and disadvantaged populations

Nephrology

Volumn 6, Issue 1, 2001, Pages 9-17

  Nelson, Robert G ^a,b  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Birth weight; Diabetic nephropathy; Genetics; Glomerular filtration rate; Intrauterine environment; Linkage analysis; Risk factors; Segregation analysis; Type 2 diabetes mellitus

Indexed keywords

DEVELOPING COUNTRY; DIABETIC NEPHROPATHY; EPIDEMIC; HEALTH CARE ACCESS; HUMAN; LIFESTYLE; MALNUTRITION; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POVERTY; PRIORITY JOURNAL; REVIEW; SOCIAL STATUS; SURVIVAL RATE;

EID: 0035053911     PISSN: 13205358     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1797.2001.00025.x     Document Type: Review

References (75)

1. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections
2. Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus
3. Mortality among diabetics in a national sample
4. The kidney in maturity onset diabetes mellitus: A clinical study of 510 patients
5. Microalbuminuria: A major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients
6. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes
7. NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community
8. Diabetic kidney disease in Pima Indians
9. Increased incidence of end-stage renal failure secondary to diabetes mellitus in Asian ethnic groups in the United Kingdom
10. An epidemic of renal failure among Australian Aboriginals
11. Westernisation, insulin resistance and diabetes in Australian Aborigines
12. Diabetes epidemiology as a tool to trigger diabetes research and care
13. Diabetes in African Americans
14. Diabetes in Hispanic Americans
15. Diabetes in Asian and Pacific Islander Americans
16. Diabetes in North American Indians and Alaska Natives
17. Incidence of end-stage renal disease in type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians
18. Familial predisposition to renal disease in two generations of Pima Indians with Type 2 (non-insulin-dependent) diabetes mellitus
19. The familial risk of end-stage renal disease in African Americans
20. Clustering of albumin excretion rate abnormalities in Caucasian patients with NIDDM
21. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients
22. Parental hypertension and proteinuria in Pima Indians with NIDDM
23. Predisposition to essential hypertension and development of diabetic nephropathy in IDDM patients
24. The angiotensin-I converting enzyme (ACE) gene I/D polymorphism and ACE levels in Pima Indians
25. Genetic predisposition to diabetic nephropathy. Evidence for a role of the angiotensin I-converting enzyme gene
26. Relationship between angiotensin I converting enzyme gene polymorphism, plasma levels and diabetic retinal and renal complications
27. Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients
28. Angiontensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in NIDDM
29. Association of ACE gene polymorphism and diabetic nephropathy?
30. A molecular variant of the angiotensinogen is associated with diabetic nephropathy in IDDM
31. Angiotensinogen polymorphism M235T, hypertension, and nephropathy in insulin-dependent diabetes
32. Angiotensinogen gene polymorphism in IDDM patients with diabetic nephropathy
33. Synergistic effect of angiotensin-II type 1 receptor genotype and poor glycemic control on risk of nephropathy in IDDM
34. + antiporter as a candidate gene in human hypertension
35. Segregation analysis of diabetic nephropathy in Pima Indians
36. Segregation analysis of urinary albumin excretion in families with type 2 diabetes
37. Genetic Analysis Workshop II. Sib pair screening test for linkage
38. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes
39. An autosomal genomic scan for loci linked to type II diabetes mellitus and body-mass index in Pima Indians
40. A comprehensive genetic map of the human genome based on 5264 microsatellites
41. A comprehensive human linkage map with centimorgan density. Cooperative Human Linkage Center (CHLC)
42. The human aldose reductase gene maps to chromosome region 7q35
43. Physical mapping of the human T-cell receptor beta gene complex, using yeast artificial chromosomes
44. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene
45. The role of aldose reductase gene in the susceptibility to diabetic nephropathy in type II (non-insulin-dependent) diabetes mellitus
46. Angiotensin I converting enzyme gene is on chromosome 17
47. Assignment by in situ hybridization of the angiotensinogen gene to chromosome band 1q4, the same region as the human renin gene
48. + antiporter gene, identification of genetic polymorphisms, and localization on the genetic map on chromosome 1p
49. Report of the second international workshop on the human chromosome 3 mapping
50. Development of human kidney as shown by microdissection. III. Formation and interrelationships of collecting tubules and nephrons
51. Human intra-uterine renal growth expressed in absolute number of glomeruli assessed by the 'Dissector' method and Cavalieri principle
52. Congenital oligonephropathy and the etiology of adult hypertension and progressive renal injury
53. The effect of intrauterine growth retardation on the development of renal nephrons
54. Low birthweight and renal disease in Australian aborigines
55. The multidimensional nature of renal disease: Rates and associations of albuminuria in an Australian Aboriginal community
56. Birth weight and renal disease in Pima Indians with type 2 diabetes mellitus
57. Unfavorable course of minimal change nephrotic syndrome in children with intrauterine growth retardation
58. Intrauterine diabetes exposure and the risk of renal disease in diabetic Pima Indians
59. Diabetes and obesity in the Pima Indians: A cross-generational vicious cycle
60. Increasing prevalence of Type II diabetes in American Indian children
61. An epidemic of proteinuria in Pima Indians with type 2 diabetes mellitus
62. Diabetic nephropathy in type 1 (insulin-dependent) diabetes: An epidemiological study
63. The changing natural history of nephropathy in type 1 diabetes
64. Declining incidence of persistent proteinuria in type 1 (insulin-dependent) diabetic patients in Denmark
65. Increased urinary albumin excretion rate in benign essential hypertension
66. Pro-diabetic blood pressure predicts urinary albumin excretion after the onset of Type 2 (non-insulin-dependent) diabetes mellitus in Pima Indians
67. Incidence and determinants of elevated urinary albumin excretion in Pima Indians with NIDDM
68. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: Prospective, observational study
69. The case for intrarenal hypertension in the initiation and progression of diabetic and other glomerulopathies
70. Glomerular hyperfiltration in young Polynesians with type 2 diabetes
71. Angiotensin II modulates glomerular capillary permselectivity in rat isolated perfused kidney
72. Mechanism of angiotensin II-induced proteinuria in the rat
73. Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?
74. Glomerular function in Pima Indians with noninsulin-dependent diabetes mellitus of recent onset